Abbott Receives U.S. Approval of Next-Generation MitraClip®

Abbott announced that its fourth-generation MitraClip device, MitraClip G4, was approved by the US Food and Drug Administration on July 15, 2019, to treat mitral regurgitation (MR) in a wider population of patients.  The MitraClip G4 include new clip sizes and an enhanced leaflet grasping feature

More flexibility with four unique clip sizes, including clips with a wider grasping area to provide additional treatment options
Independently controlled grippers that better help with the grasp of one or both mitral leaflets during transcatheter mitral valve interventions
Upgraded MitraClip catheter can be integrated with a commercially available pressure monitor to continuously track and confirm MR reduction during the implant procedure